Related Experiment Video
Updated: Aug 14, 2025

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Exploring the mechanism of C473D mutation on CDC25B causing weak binding affinity with CDK2/CyclinA by molecular
Li-Peng Li1, Hao-Xin Li1, Hui Zhou1
1Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, People's Republic of China.
The CDC25B C473D mutation weakens binding to CDK2/CyclinA by reducing system stability and altering key residue interactions. This study clarifies the mechanism behind reduced affinity in the CDC25B C473D mutant, impacting cancer development research.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- CDC25B is a key regulator of CDK/CyclinA activity and is implicated in cancer development.
- A specific mutation, CYS473 to ASP (CDC25B C473D), weakens the binding affinity between CDC25B and CDK2/CyclinA, but the underlying mechanism is not fully understood.
Purpose of the Study:
- To investigate the molecular mechanism by which the CDC25B C473D mutation affects the interaction with CDK2/CyclinA.
- To analyze the stability and binding dynamics of the wild-type CDC25B (CDC25B WT) and mutant CDC25B C473D in complex with CDK2/CyclinA.
Main Methods:
- Construction and verification of CDC25B WT:CDK2/CyclinA and CDC25B C473D:CDK2/CyclinA systems.
- Molecular dynamics (MD) simulations and post-simulation analysis of residue fluctuations and interactions.
Main Results:
- The CDC25B C473D:CDK2/CyclinA system exhibited increased residue fluctuations in specific regions (ARG488-SER499, LYS541-TRP550 on CDC25B; ASP206-ASP210 on CDK2).
- Weakened interactions were observed between key residues, including ARG492-GLU208, ARG544-GLU42, and ARG544-TRP550 in the mutant system.
- The mutant CDC25B C473D:CDK2/CyclinA system demonstrated lower stability compared to the wild-type system.
Conclusions:
- The mutation at active site CYS473 is critical for the binding stability between CDC25B and CDK2/CyclinA.
- The study provides insights into the reduced binding affinity of CDC25B C473D to CDK2/CyclinA, relevant for understanding its role in cancer.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex
DNA Damage can Stall the Cell Cycle